Chemotherapy-induced senescent cancer cells engulf other cells to enhance their survival
Open accessThe DOI matches its Crossref record; 58 of the 59 references it cites were found in a registry or an index.
Abstract
In chemotherapy-treated breast cancer, wild-type p53 preferentially induces senescence over apoptosis, resulting in a persisting cell population constituting residual disease that drives relapse and poor patient survival via the senescence-associated secretory phenotype. Understanding the properties of tumor cells that allow survival after chemotherapy treatment is paramount. Using time-lapse and confocal microscopy to observe interactions of cells in treated tumors, we show here that chemotherapy-induced senescent cells frequently engulf both neighboring senescent or nonsenescent tumor cells at a remarkable frequency. Engulfed cells are processed through the lysosome and broken down, and cells that have engulfed others obtain a survival advantage. Gene expression analysis showed a marked up-regulation of conserved macrophage-like program of engulfment in chemotherapy-induced senescent cell lines and tumors. Our data suggest compelling explanations for how senescent cells persist in dormancy, how they manage the metabolically expensive process of cytokine production that drives relapse in those tumors that respond the worst, and a function for their expanded lysosomal compartment.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures








Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Although still poorly understood, chemotherapy-resistant senescent cells can engulf neighboring normal and tumor cells by phagocytosis for survival advantage [229].”
From Mechanisms and Regulation of Cellular Senescence (2021) · cites this paper as [229]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A new mathematical model for relative quantification in real-time RT-PCR
Pfaffl, M. W. (2001) · Nucleic Acids Research · doi:10.1093/nar/29.9.e45 · Cited by 34,610 · cited 1×
“Real-time PCR was performed on a QuantStudio6 (Applied Biosystems) using Sybr Green (Bio-Rad) and analysis as per Pfaffl (2001), as previously described (Jackson et al., 2012).”
MethodA biomarker that identifies senescent human cells in culture and in aging skin in vivo.
Dimri, G. P., Lee, X., Basile, G., Acosta, M., Scott, G., Roskelley, C., Medrano, E. E., Linskens, M., Rubelj, I., & Pereira-Smith, O. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.20.9363 · Cited by 7,477
In Vivo Activation of the p53 Pathway by Small-Molecule Antagonists of MDM2
Vassilev, L. T., Vu, B. T., Graves, B., Carvajal, D., Podlaski, F., Filipovic, Z., Kong, N., Kammlott, U., Lukacs, C., Klein, C., et al. (2004) · Science · doi:10.1126/science.1092472 · Cited by 4,661
Persistent DNA damage signalling triggers senescence-associated inflammatory cytokine secretion
Rodier, F., Coppé, J.-P., Patil, C. K., Hoeijmakers, W. A. M., Muñoz, D. P., Raza, S. R., Freund, A., Campeau, E., Davalos, A. R., & Campisi, J. (2009) · Nature Cell Biology · doi:10.1038/ncb1909 · Cited by 2,232
Senescence-associated β-galactosidase is lysosomal β-galactosidase.
Lee, B. Y., Han, J. A., Im, J. S., Morrone, A., Johung, K., Goodwin, E. C., Kleijer, W. J., DiMaio, D., & Hwang, E. S. (2006) · Aging Cell · doi:10.1111/j.1474-9726.2006.00199.x · Cited by 1,444 · cited 2×
“…senescent cells process engulfed cells to the lysosome Senescent cells have a vastly expanded lysosomal compartment that is detected by the SA-βGAL assay (Kurz et al., 2000; Lee et al., 2006), which is used widely as a marker for senescence (Dimri et al., 1995; Sharpless and Sherr, 2015).”
BackgroundForging a signature of in vivo senescence
Sharpless, N. E., & Sherr, C. J. (2015) · Nature Reviews Cancer · doi:10.1038/nrc3960 · Cited by 1,104 · cited 3×
“, 2006), is a well-described feature of many senescent cell types, both in vivo and in vitro, in normal and cancer cells (Jackson et al., 2012; Sharpless and Sherr, 2015), including chemotherapytreated breast cancers (te Poele et al.”
BackgroundInfluentialDisruption of p53 in human cancer cells alters the responses to therapeutic agents.
Bunz, F., Hwang, P. M., Torrance, C., Waldman, T., Zhang, Y., Dillehay, L., Williams, J., Lengauer, C., Kinzler, K. W., & Vogelstein, B. (1999) · Journal of Clinical Investigation · doi:10.1172/jci6863 · Cited by 1,044 · cited 1×
“TP53 mutant cells are more sensitive to DNA damage (Brown and Wouters, 1999; Bunz et al., 1999), but cells that survive can undergo p53-independent senescence in culture (Chang et al.”
BackgroundKurz, D. J., Decary, S., Hong, Y., & Erusalimsky, J. D. (2000) · Journal of Cell Science · doi:10.1242/jcs.113.20.3613 · Cited by 899
Encinas, M., Iglesias, M., Liu, Y., Wang, H., Muhaisen, A., Ceña, V., Gallego, C., & Comella, J. X. (2000) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2000.0750991.x · Cited by 820
Apoptosis, p53, and tumor cell sensitivity to anticancer agents.
Brown, J. M., & Wouters, B. G. (1999) · PubMed · Cited by 771
A Nonapoptotic Cell Death Process, Entosis, that Occurs by Cell-in-Cell Invasion
Overholtzer, M., Mailleux, A. A., Mouneimne, G., Normand, G., Schnitt, S. J., King, R. W., Cibas, E. S., & Brugge, J. S. (2007) · Cell · doi:10.1016/j.cell.2007.10.040 · Cited by 748 · cited 4×
“Our phenotype was induced over time by chemotherapy treatment and senescence, not acutely after loss of substrate adherence (Overholtzer et al., 2007) or mitotic rounding (Durgan et al.”
BackgroundMethodInfluential(2002) · PubMed · Cited by 640
(1999) · PubMed · Cited by 546
Toso, A., Revandkar, A., Di Mitri, D., Guccini, I., Proietti, M., Sarti, M., Pinton, S., Zhang, J., Kalathur, M., Civenni, G., et al. (2014) · Cell Reports · doi:10.1016/j.celrep.2014.08.044 · Cited by 418 · cited 1×
“The SASP can promote tumorigenic properties such as proliferation, survival, stemness, immune evasion, and metastasis (Rodier et al., 2009; Achuthan et al., 2011; Cahu et al., 2012; Canino et al., 2012; Toso et al., 2014; Rao and Jackson, 2016).”
BackgroundChang, B.-D., Xuan, Y., Broude, E. V., Zhu, H., Schott, B., Fang, J., & Roninson, I. B. (1999) · Oncogene · doi:10.1038/sj.onc.1203078 · Cited by 386
The I-SPY 1 TRIAL Investigators, Esserman, L. J., Berry, D. A., Cheang, M. C. U., Yau, C., Perou, C. M., Carey, L., DeMichele, A., Gray, J. W., Conway-Dorsey, K., et al. (2012) · Breast Cancer Research and Treatment · doi:10.1007/s10549-011-1895-2 · Cited by 362
Jackson, J. G., Pant, V., Li, Q., Chang, L. L., Quintás-Cardama, A., Garza, D., Tavana, O., Yang, P., Manshouri, T., Li, Y., et al. (2012) · Cancer Cell · doi:10.1016/j.ccr.2012.04.027 · Cited by 329
Self-citationMetabolic analysis of senescent human fibroblasts reveals a role for AMP in cellular senescence
ZWERSCHKE, W., MAZUREK, S., STÖCKL, P., HÜTTER, E., EIGENBRODT, E., & JANSEN-DÜRR, P. (2003) · Biochemical Journal · doi:10.1042/bj20030816 · Cited by 247 · cited 1×
“Furthermore, these cells are metabolically very different from nonsenescent cells (Zwerschke et al., 2003; Erol, 2010; Kim et al., 2010, 2011; Quijano et al., 2012; Gey and Seeger, 2013), producing and secreting cytokines and chemokines that contribute to relapse (Jackson et al.”
BackgroundCompetition between human cells by entosis
Sun, Q., Luo, T., Ren, Y., Florey, O., Shirasawa, S., Sasazuki, T., Robinson, D. N., & Overholtzer, M. (2014) · Cell Research · doi:10.1038/cr.2014.138 · Cited by 233 · cited 1×
“Rather than increasing engulfment relatively quickly due to physical changes caused by loss of substrate adherence that result in cells that happen to be highly deformable in suspension ingesting cells that are less deformable (Sun et al., 2014b), our phenotype required days to develop and was driven by a macrophage/p…”
BackgroundDrug-induced Senescence Generates Chemoresistant Stemlike Cells with Low Reactive Oxygen Species
Achuthan, S., Santhoshkumar, T. R., Prabhakar, J., Nair, S. A., & Pillai, M. R. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.200675 · Cited by 208 · cited 1×
“The SASP can promote tumorigenic properties such as proliferation, survival, stemness, immune evasion, and metastasis (Rodier et al., 2009; Achuthan et al., 2011; Cahu et al., 2012; Canino et al., 2012; Toso et al., 2014; Rao and Jackson, 2016).”
BackgroundSASP: Tumor Suppressor or Promoter? Yes!
Rao, S. G., & Jackson, J. G. (2016) · Trends in Cancer · doi:10.1016/j.trecan.2016.10.001 · Cited by 206 · cited 2×
“, 2012; Gey and Seeger, 2013), producing and secreting cytokines and chemokines that contribute to relapse (Jackson et al., 2012; Velarde et al., 2013; Rao and Jackson, 2016).”
BackgroundSelf-citationEntosis Is Induced by Glucose Starvation
Hamann, J. C., Surcel, A., Chen, R., Teragawa, C., Albeck, J. G., Robinson, D. N., & Overholtzer, M. (2017) · Cell Reports · doi:10.1016/j.celrep.2017.06.037 · Cited by 203
SASP mediates chemoresistance and tumor-initiating-activity of mesothelioma cells
Canino, C., Mori, F., Cambria, A., Diamantini, A., Germoni, S., Alessandrini, G., Borsellino, G., Galati, R., Battistini, L., Blandino, R., et al. (2012) · Oncogene · doi:10.1038/onc.2011.485 · Cited by 200
Bertheau, P., Turpin, E., Rickman, D. S., Espié, M., de Reyniès, A., Feugeas, J.-P., Plassa, L.-F., Soliman, H., Varna, M., de Roquancourt, A., et al. (2007) · PLoS Medicine · doi:10.1371/journal.pmed.0040090 · Cited by 173 · cited 2×
“In response to chemotherapy, TP53 wild-type human breast tumors rarely undergo pathological complete response (Bertheau et al., 2002, 2007; Chen et al., 2012; Esserman et al., 2012; Nakamura et al., 2012; Wang et al., 2016; Goetz et al., 2017), and these patients have poor survival (Ungerleider et…”
BackgroundJackson, J. G., White, M. F., & Yee, D. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.16.9994 · Cited by 171
Self-citationCancer cells enter dormancy after cannibalizing mesenchymal stem/stromal cells (MSCs)
Bartosh, T. J., Ullah, M., Zeitouni, S., Beaver, J., & Prockop, D. J. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1612290113 · Cited by 164 · cited 1×
“Following the engulfment, dormancy and senescent phenotypes were then induced in the engulfing breast cancer cell (Bartosh et al., 2016).”
BackgroundSenescence-associated secretory phenotype favors the emergence of cancer stem-like cells
Cahu, J., Bustany, S., & Sola, B. (2012) · Cell Death & Disease · doi:10.1038/cddis.2012.183 · Cited by 160 · cited 1×
“The SASP can promote tumorigenic properties such as proliferation, survival, stemness, immune evasion, and metastasis (Rodier et al., 2009; Achuthan et al., 2011; Cahu et al., 2012; Canino et al., 2012; Toso et al., 2014; Rao and Jackson, 2016).”
BackgroundEffect of mutated TP53 on response of advanced breast cancers to high-dose chemotherapy
Bertheau, P., Plassa, F., Espié, M., Turpin, E., de Roquancourt, A., Marty, M., Lerebours, F., Beuzard, Y., Janin, A., & de Thé, H. (2002) · The Lancet · doi:10.1016/s0140-6736(02)09969-5 · Cited by 159 · cited 1×
“These factors suggest immediate clinical relevance, as p53-mediated induction of senescence contributes to poor response (Bertheau et al., 2002; Jackson et al., 2012) and poor survival (Ungerleider et al.”
BackgroundOncogene-induced senescence results in marked metabolic and bioenergetic alterations
Quijano, C., Cao, L., Fergusson, M. M., Romero, H., Liu, J., Gutkind, S., Rovira, I. I., Mohney, R. P., Karoly, E. D., & Finkel, T. (2012) · Cell Cycle · doi:10.4161/cc.19800 · Cited by 155 · cited 2×
“Furthermore, these cells are metabolically very different from nonsenescent cells (Zwerschke et al., 2003; Erol, 2010; Kim et al., 2010, 2011; Quijano et al., 2012; Gey and Seeger, 2013), producing and secreting cytokines and chemokines that contribute to relapse (Jackson et al.”
BackgroundInduction of entosis by epithelial cadherin expression
Sun, Q., Cibas, E. S., Huang, H., Hodgson, L., & Overholtzer, M. (2014) · Cell Research · doi:10.1038/cr.2014.137 · Cited by 148
E-Cadherin/ROS1 Inhibitor Synthetic Lethality in Breast Cancer
Bajrami, I., Marlow, R., van de Ven, M., Brough, R., Pemberton, H. N., Frankum, J. R., Song, F., Rafiq, R., Konde, A., Krastev, D. B., et al. (2018) · Cancer Discovery · doi:10.1158/2159-8290.cd-17-0603 · Cited by 136 · cited 2×
“MCF-7 CDH1 KO cells have been described (Bajrami et al., 2018) and were compared with the parental MCF-7 from which they were”
BackgroundSelf-citationMechanisms and consequences of entosis
Krishna, S., & Overholtzer, M. (2016) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-016-2207-0 · Cited by 118 · cited 1×
“There are many observed types of cell engulfment, including phagocytosis and efferocytosis of apoptotic or dying cells by macrophages or other nonprofessional phagocytes (Gray and Botelho, 2017), emperipolesis, and entosis (Overholtzer et al., 2007; Krishna and Overholtzer, 2016; Durgan et al., 2017; Hamann et al., 20…”
BackgroundMitosis can drive cell cannibalism through entosis
Durgan, J., Tseng, Y.-Y., Hamann, J. C., Domart, M.-C., Collinson, L., Hall, A., Overholtzer, M., & Florey, O. (2017) · eLife · doi:10.7554/elife.27134 · Cited by 117 · cited 2×
“Our phenotype was induced over time by chemotherapy treatment and senescence, not acutely after loss of substrate adherence (Overholtzer et al., 2007) or mitotic rounding (Durgan et al., 2017).”
BackgroundBreast cancer survival predicted by TP53 mutation status differs markedly depending on treatment
Ungerleider, N., Rao, S. G., Shahbandi, A., Yee, D., Niu, T., Frey, W. D., & Jackson, J. G. (2018) · Breast Cancer Research · doi:10.1186/s13058-018-1044-5 · Cited by 117 · cited 2×
“, 2017), and these patients have poor survival (Ungerleider et al., 2018).”
BackgroundSelf-citationSenescent Cells and Their Secretory Phenotype as Targets for Cancer Therapy
Velarde, M. C., Demaria, M., & Campisi, J. (2013) · Interdisciplinary Topics in Gerontology and Geriatrics · doi:10.1159/000343572 · Cited by 112 · cited 1×
“, 2012; Gey and Seeger, 2013), producing and secreting cytokines and chemokines that contribute to relapse (Jackson et al., 2012; Velarde et al., 2013; Rao and Jackson, 2016).”
BackgroundJackson, J. G., & Pereira-Smith, O. M. (2006) · Molecular and Cellular Biology · doi:10.1128/mcb.26.7.2501-2510.2006 · Cited by 108
Self-citationHow Mouse Macrophages Sense What Is Going On
Ley, K., Pramod, A. B., Croft, M., Ravichandran, K. S., & Ting, J. P. (2016) · Frontiers in Immunology · doi:10.3389/fimmu.2016.00204 · Cited by 101
Rastogi, S., Joshi, B., Dasgupta, P., Morris, M., Wright, K., & Chellappan, S. (2006) · Molecular and Cellular Biology · doi:10.1128/mcb.02142-05 · Cited by 90 · cited 4×
“Indeed, we found that in two TP53 mutant breast cancer cell lines shown to become senescent after chemotherapy, BT474 (Rosemblit et al., 2018) and T47D (Rastogi et al., 2006), cells that survived chemotherapy could engulf neighboring NT cells (Fig.”
BackgroundInfluentialMitosis can drive cell cannibalism through entosis.
Durgan, J., Tseng, Y., Hamann, J. C., Domart, M., Collinson, L., Hall, A. K., Overholtzer, M., & Florey, O. (2017) · Figshare · doi:10.17863/cam.41122 · Cited by 81
Tumor Sequencing and Patient-Derived Xenografts in the Neoadjuvant Treatment of Breast Cancer
Goetz, M. P., Kalari, K. R., Suman, V. J., Moyer, A. M., Yu, J., Visscher, D. W., Dockter, T. J., Vedell, P. T., Sinnwell, J. P., Tang, X., et al. (2017) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djw306 · Cited by 80
Proteomic and metabolomic analysis of H2O2-induced premature senescent human mesenchymal stem cells
Kim, J. S., Kim, E.-J., Kim, H. J., Yang, J.-Y., Hwang, G., & Kim, C. (2011) · Experimental Gerontology · doi:10.1016/j.exger.2011.02.012 · Cited by 72
Huang, B., Deo, D., Xia, M., & Vassilev, L. T. (2009) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-09-0144 · Cited by 72
Shahbandi, A., & Jackson, J. G. (2019) · npj Precision Oncology · doi:10.1038/s41698-018-0074-x · Cited by 65 · cited 11×
“The TP53-edited MCF-7 cells that survived chemotherapy were SA-βGAL positive and adopted classic morphological changes consistent with senescent cells (Fig.”
BackgroundSelf-citationPhagocytosis: Hungry, Hungry Cells
Gray, M. A., & Botelho, R. J. (2016) · Methods in molecular biology · doi:10.1007/978-1-4939-6581-6_1 · Cited by 60
Systemic DNA Damage Response and Metabolic Syndrome as a Premalignant State
Erol, A. (2010) · Current Molecular Medicine · doi:10.2174/156652410791065282 · Cited by 57 · cited 1×
“Furthermore, these cells are metabolically very different from nonsenescent cells (Zwerschke et al., 2003; Erol, 2010; Kim et al., 2010, 2011; Quijano et al., 2012; Gey and Seeger, 2013), producing and secreting cytokines and chemokines that contribute to relapse (Jackson et al., 2012; Velarde et…”
BackgroundMetabolic changes during cellular senescence investigated by proton NMR-spectroscopy
Gey, C., & Seeger, K. (2013) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2013.02.002 · Cited by 55
Anticancer chemotherapy and radiotherapy trigger both non-cell-autonomous and cell-autonomous death
Martins, I., Raza, S. Q., Voisin, L., Dakhli, H., Allouch, A., Law, F., Sabino, D., de Jong, D., Thoreau, M., Mintet, E., et al. (2018) · Cell Death and Disease · doi:10.1038/s41419-018-0747-y · Cited by 55 · cited 2×
“Rates of entosis can be increased by glucose starvation (Hamann et al., 2017) or 12–48 h after radiation/chemotherapy treatment (Martins et al., 2018).”
BackgroundLitwiniec, A., Grzanka, A., Helmin–Basa, A., Gackowska, L., & Grzanka, D. (2009) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-009-0711-4 · Cited by 50 · cited 1×
“Two non–breast cell lines that are TP53 wild type and undergo chemotherapy-induced senescence, A549 lung adenocarcinoma and U2OS osteosarcoma (Litwiniec et al., 2010; Anwar et al., 2018), also engulfed neighboring NT cells 7–8 d after doxorubicin treatment (Fig.”
BackgroundChen, M., Zhu, Y., Xu, J., Wang, L., Liu, C., Ji, Z., & Lu, P. (2012) · PLoS ONE · doi:10.1371/journal.pone.0039655 · Cited by 43
Wang, Y., Xu, Y., Chen, J., Ouyang, T., Li, J., Wang, T., Fan, Z., Fan, T., Lin, B., & Xie, Y. (2015) · International Journal of Cancer · doi:10.1002/ijc.29715 · Cited by 40 · cited 1×
“Introduction In response to chemotherapy, TP53 wild-type human breast tumors rarely undergo pathological complete response (Bertheau et al., 2002, 2007; Chen et al., 2012; Esserman et al., 2012; Nakamura et al., 2012; Wang et al., 2016; Goetz et al., 2017), and these patients have poor survival (Ungerleider et al.”
BackgroundRosemblit, C., Datta, J., Lowenfeld, L., Xu, S., Basu, A. B., Kodumudi, K. N., Wiener, D. A., & Czerniecki, B. J. (2018) · Oncotarget · doi:10.18632/oncotarget.25208 · Cited by 39 · cited 4×
“Indeed, we found that in two TP53 mutant breast cancer cell lines shown to become senescent after chemotherapy, BT474 (Rosemblit et al., 2018) and T47D (Rastogi et al., 2006), cells that survived chemotherapy could engulf neighboring NT cells (Fig.”
BackgroundInfluentialJackson, J. G., & Yee, D. (1999) · Growth Hormone & IGF Research · doi:10.1054/ghir.1999.0113 · Cited by 25
Self-citationAziz, M., Yang, W., & Wang, P. (2013) · Current Protocols in Immunology · doi:10.1002/0471142735.im1431s100 · Cited by 25 · cited 1×
“To determine if senescent cells gained proficiency in phagocytosis, we performed an established assay using apoptotic Jurkat cells labeled with pHrodo dye that become fluorescent in the acidic pH of the lysosome following phagocytosis (Aziz et al., 2013).”
MethodLee (2010) · Oncology Reports · doi:10.3892/or_00000872 · Cited by 21
Methods for the Study of Entosis
Sun, Q., & Overholtzer, M. (2013) · Methods in Molecular Biology · doi:10.1007/978-1-62703-383-1_5 · Cited by 17 · cited 4×
“, 2007), entosis was frequent and easily identified in MCF-7 cells using standard assays (Sun and Overholtzer, 2013).”
BackgroundInfluentialTonnessen-Murray, C. A., Ungerleider, N., Rao, S. G., Wasylishen, A. R., Frey, W. D., & Jackson, J. G. (2018) · Translational Oncology · doi:10.1016/j.tranon.2018.05.003 · Cited by 15 · cited 10×
“Lentiviral infections Fluorescent protein inserts (cytoplasmic GFP and mCherry, in the backbone CD502A-1 [pCDH-EF1α-MCS cDNA Single Promoter Cloning and Expression Lentivector] from Systems Biosciences; LAMP-GFP [34831]; mCherry-Farnesyl for membranes [55045]; H2B-GFP [21210]; and H2B-mCherry [21217] from Addgene) wer…”
BackgroundMethodSelf-citationAnwar, T., Sen, B., Aggarwal, S., Nath, R., Pathak, N., Katoch, A., Aiyaz, M., Trehanpati, N., Khosla, S., & Ramakrishna, G. (2017) · Journal of Cellular Physiology · doi:10.1002/jcp.26227 · Cited by 14 · cited 1×
“Two non–breast cell lines that are TP53 wild type and undergo chemotherapy-induced senescence, A549 lung adenocarcinoma and U2OS osteosarcoma (Litwiniec et al., 2010; Anwar et al., 2018), also engulfed neighboring NT cells 7–8 d after doxorubicin treatment (Fig.”
BackgroundNakamura, Y. K., Oshima, K., Naoi, Y., Nakayama, T., Kim, S. J., Shimazu, K., Shimomura, A., Maruyama, N., Tamaki, Y., & Noguchi, S. (2012) · Breast Cancer Research and Treatment · doi:10.1007/s10549-012-1976-x · Cited by 12 · cited 1×
“Introduction In response to chemotherapy, TP53 wild-type human breast tumors rarely undergo pathological complete response (Bertheau et al., 2002, 2007; Chen et al., 2012; Esserman et al., 2012; Nakamura et al., 2012; Wang et al., 2016; Goetz et al., 2017), and these patients have poor survival (Ungerleider et al.”
Background
Research works printed but not linked: 1
- Tonnessen-Murray C., Lozano G., and Jackson J.G. 2016 The p53 Protein: From Cell Regulation to Cancer. In Lozano G., and Levine A.J., editors. The p53 Protein: From Cell Regulation to Cancer. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY 173– 186.
Cited by
Cellular senescence: the good, the bad and the unknown
Huang, W., Hickson, L. J., Eirin, A., Kirkland, J. L., & Lerman, L. O. (2022) · Nature Reviews Nephrology · doi:10.1038/s41581-022-00601-z · Cited by 1,150
Mechanisms and Regulation of Cellular Senescence
Roger, L., Tomas, F., & Gire, V. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222313173 · Cited by 395
“Indeed, upon engulfment and processing through lysosomes of these cells, biosynthetic material and energy are released to sustain the high metabolic needs of senescent cells [229].”
BackgroundPersistent Cancer Cells: The Deadly Survivors
Shen, S., Vagner, S., & Robert, C. (2020) · Cell · doi:10.1016/j.cell.2020.10.027 · Cited by 304
Therapy-Induced Senescence: An “Old” Friend Becomes the Enemy
Saleh, T., Bloukh, S., Carpenter, V. J., Alwohoush, E., Bakeer, J., Darwish, S., Azab, B., & Gewirtz, D. A. (2020) · Cancers · doi:10.3390/cancers12040822 · Cited by 290
TP53 Mutations and Outcomes in Breast Cancer: Reading beyond the Headlines
Shahbandi, A., Nguyen, H. D., & Jackson, J. G. (2020) · Trends in Cancer · doi:10.1016/j.trecan.2020.01.007 · Cited by 226
Self-citation
Metadata
- Authors
- Tonnessen-Murray, C. A., Frey, W. D., Rao, S. G., Shahbandi, A., Ungerleider, N. A., Olayiwola, J. O., Murray, L. B., Vinson, B. T., Chrisey, D. B., Lord, C. J., & Jackson, J. G.
- Affiliations
- Tulane University (US)
- Institute of Cancer Research (GB)
- Corresponding author
- Jackson, James G.
- ORCID
- Venue
- Journal of Cell Biology
- Publisher
- Rockefeller University Press
- Published
- 2019-09-17
- Volume
- 218
- Issue
- 11
- Pages
- 3827-3844
- ISSN
- 0021-9525 (ISSN-L)
- 1540-8140
- PMC
- PMC6829672
- OpenAlex
- W2973542731
- Cited by
- 127
- References
- 59
- Citations by year
- 2026: 7 · 2025: 11 · 2024: 23 · 2023: 16 · 2022: 20 · 2021: 18 · 2020: 25 · 2019: 6
- FWCI
- 11.83
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- The Journal of Cell Biology (publishedVersion, cc-by-nc-sa)
- PubMed Central (publishedVersion, cc-by-nc-sa)
- PubMed (publishedVersion)
- Funders
- U.S. Department of Defense (W81XWH-14-1-0216)
- National Institutes of Health
- National Institute of General Medical Sciences (1P30GM114732-01, U54 GM104940)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Autophagy in Disease and Therapy
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Cell death mechanisms and regulation
- Keywords
- chemotherapy-induced senescence, senescence-associated secretory phenotype, breast cancer, p53, cell engulfment, lysosomal degradation, tumor cell survival, relapse, cytokine production, lysosomes
- MeSH terms
- Animals, Antibiotics, Antineoplastic, Cell Survival, Doxorubicin, Humans, Tumor Cells, Cultured, Cellular Senescence, Cell Proliferation, Mice, MCF-7 Cells
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.